Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of 7MW3711 in advanced solid tumors
CTR20232441Phase 2Active
- Sponsor
- Maiwei Biotech
- Start
- Aug 2023
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 7MW3711 in Nonhematologic neoplasms, sponsored by Maiwei Biotech. Started Aug 2023; status: active.
02
Drugs
7MW3711
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20232441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232441.